Scientific Reports (May 2022)

7-Methoxyisoflavone ameliorates atopic dermatitis symptoms by regulating multiple signaling pathways and reducing chemokine production

  • Hao Dong,
  • Chenjie Feng,
  • Xiyunyi Cai,
  • Yuanyuan Hao,
  • Xinyue Gu,
  • Lei Cai,
  • Shuting Wu,
  • Jiamin Chen,
  • Zhou Liu,
  • Wen Xie,
  • Xuanren Lu,
  • Hongfa Qian,
  • Yulin Liu,
  • Yiming Cao,
  • Junlin Zhu,
  • Jiayi Xu,
  • Yanjie Zhou,
  • Shuangyu Ma,
  • Sha Yang,
  • Yufeng Shi,
  • Haojiang Yu,
  • Minjie Shi,
  • Yurong Wang,
  • Harvest F. Gu,
  • Lei Fan,
  • Liang Wu

DOI
https://doi.org/10.1038/s41598-022-12695-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Abstract 7-Met, a derivative of soybean isoflavone, is a natural flavonoid compound that has been reported to have multiple signaling pathways regulation effects. This study investigated the therapeutic effects of 7-Met on mice with atopic dermatitis induced by fluorescein isothiocyanate (FITC), or oxazolone (OXZ). 7-Met ameliorated FITC or OXZ-induced atopic dermatitis symptoms by decreasing ear thickness, spleen index, mast cell activation, neutrophil infiltration and serum IgE levels in female BALB/c mice. In FITC-induced atopic dermatitis mice, 7-Met reduced Th1 cytokines production and regulated Th1/Th2 balance by downregulating the secretion of thymic stromal lymphopoietin (TSLP) via inactivation of the NF-κB pathway. In OXZ-induced atopic dermatitis, 7-Met functioned through the reduction of Th17 cytokine production. Our study showed that 7-Methoxyisoflavone alleviated atopic dermatitis by regulating multiple signaling pathways and downregulating chemokine production.